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Abstract
Rabkin, et al. describes a 4% incidence qfphenelzine-inducededema, which appears to bedue
to increased capillary permeability (1,2). This adverse dJect is not furth er characterized ill the
literature and is not readily mentioned as oneofthe maiD' drug effects that could result in severe
physical morbidity. We present the case qfa depressed patient who developed a generalized edema
severe enough to deserve an extensive medical workup. Once the drug was tapered, the edema and
its associated symptoms rapidly resolved.
CASE REPORT
MW is a 5 1 yea r old female with a psychi a tric hist ory of recu rr ent severe major
depression and a past medi cal history of only mild asthma. She had fail ed fluoxetine
a nd fluvoxamine afte r initial positive respon se; however, her depr essed mood would
return in settings of severe psych osocial st ress . While on a maximum dos e of
f1uvoxam in e, she expre ssed su icid al intent. MW was thus admitted for inpatient
ca re , wh ere sh e responded to ph enelzine.
Aft er hospitalizat ion, MW re maine d sta ble on ph en el zin e; however, she pr e-
se n te d afte r four months without medi cation follow-up complaining of pr ogr essive
swelling. in all ex t remities. Sh e also com pla ined of wors eni ng shortness of br eath ,
severe ly decr eased exercise toleran ce, a 50 pound weight gain and three-pill ow
orthopnea without ches t pain. C linical exam was unrema rk able except for th e
afo re me ntioned ede ma. Complet e blood count, eryt hrocyt e sed im entation rat e,
se ru m albumin, BUN/creatinine, TSH a nd urinalysis were a ll normal. A hydroch o-
lrothiazide trial fai led to bring her ede ma under contro l.
Two months lat er, MW was refer red to psychi atry for conti nue d managem ent of
her mood disorder a nd possible ph en elzin e discontinuation . Her progressive "h eart
failure-like" symptom atology had become so severe th at she was a lmost ent ire ly
dep endent on others to provide basic se lf-ca re ; thus, a slow ta per from ph en elzine
was sta r te d. Aft er being off of ph en elzin e for two weeks, MW not ed decreased
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swelling in all ex tre mit ies with a return of full range of motion. H er orthopnea a nd
exe rc ise tol erance had improved dramaticall y. Mental status exa mina tion at tha t
time revealed near resolution of her mood sym ptoms . At her next follow up
exa m ina tion 4 weeks later, sh e reported cont inue d symptom remission , with further
improvements noted in her subj ective report of mood st ate and e nergy level as a
result of con tinue d correct ion of ph enelzine-induced weight changes. She was
follow ed clinically off of medication.
The pa ti ent 's expe rie nce suggest s th at th e ede ma associa ted wit h phenelzine
ca n be quite handicapping if all owed to pr ogress. Our cli nica l experience with
ph enelzine has been very favorable, with our " typica l" case of drug-induced ede ma
cons is ting of lower ex t re mity swelling without significant se qu ela e. This expe rience
is lik ely share d by othe r cl inicia ns who mak e use of th is medica t ion; however, we
should be for ewarned th at some patients may develop severe, com plicated ede ma,
presenting health risks a nd physical morbidities th at ou twe igh th erap eu tic be nefit.
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